Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Tenapanor

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 20,192Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ardelyx Receives New Patent For Tenapanor
    Ardelyx Receives New Patent For Tenapanor

    03 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/03/3231070/0/en/Ardelyx-Receives-New-Patent-for-Tenapanor.html

    GLOBENEWSWIRE
    03 Feb 2026
    Share Share
    First Patient Dosed in Phase 3 ACCEL Study of IBSRELA
    First Patient Dosed in Phase 3 ACCEL Study of IBSRELA

    28 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/28/3227602/0/en/First-Patient-Dosed-in-ACCEL-Phase-3-Chronic-Idiopathic-Constipation-Study-of-IBSRELA.html

    GLOBENEWSWIRE
    28 Jan 2026
    Share Share
    XPHOZAH Data Shows Patient Satisfaction And Phosphate Drop
    XPHOZAH Data Shows Patient Satisfaction And Phosphate Drop

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183960/0/en/Real-World-Evidence-Studies-of-XPHOZAH-tenapanor-Demonstrate-Patient-Satisfaction-and-Reduction-in-Serum-Phosphate-with-XPHOZAH-in-Data-Presented-at-ASN-Kidney-Week.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Ardelyx Shows IBSRELA Benefits At ACG 2025 Meeting
    Ardelyx Shows IBSRELA Benefits At ACG 2025 Meeting

    28 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/28/3175386/0/en/Ardelyx-Presents-Data-that-Continues-to-Support-the-Benefits-of-IBSRELA-tenapanor-at-the-American-College-of-Gastroenterology-s-2025-Annual-Meeting.html

    GLOBENEWSWIRE
    28 Oct 2025
    Share Share
    Ardelyx To Present Four Abstracts At ASN's Kidney Week
    Ardelyx To Present Four Abstracts At ASN's Kidney Week

    21 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/21/3170125/0/en/Ardelyx-Announces-Four-Abstracts-Accepted-for-Poster-Presentations-at-the-American-Society-of-Nephrology-s-Kidney-Week.html

    GLOBENEWSWIRE
    21 Oct 2025
    Share Share
    Ardelyx Presents IBSRELA Data at Digestive Disease Week 2025
    Ardelyx Presents IBSRELA Data at Digestive Disease Week 2025

    06 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/06/3075025/0/en/Ardelyx-Presents-Data-Supporting-IBSRELA-tenapanor-at-Digestive-Disease-Week-2025-Conference.html

    GLOBENEWSWIRE
    06 May 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.